NATIXIS - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIXIS ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q2 2023$21,587
+11.7%
2,623
-1.6%
0.00%
Q1 2023$19,329
-18.3%
2,6660.0%0.00%
Q4 2022$23,647
-98.5%
2,666
-96.9%
0.00%
-100.0%
Q1 2022$1,610,000
-28.5%
84,666
-0.1%
0.01%
-25.0%
Q4 2021$2,251,000
-35.4%
84,7930.0%0.01%
-33.3%
Q3 2021$3,483,000
-34.0%
84,793
-9.0%
0.01%
-47.8%
Q2 2021$5,277,000
+20.9%
93,159
-10.3%
0.02%
+64.3%
Q1 2021$4,363,000103,8870.01%
Other shareholders
EDITAS MEDICINE INC shareholders Q1 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders